Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis

Amer Jamalpoor, Amr Othman, Elena N Levtchenko, Rosalinde Masereeuw*, Manoe J Janssen*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Nephropathic cystinosis is a severe, monogenic systemic disorder that presents early in life and leads to progressive organ damage, particularly affecting the kidneys. It is caused by mutations in the CTNS gene, which encodes the lysosomal transporter cystinosin, resulting in intralysosomal accumulation of cystine. Recent studies demonstrated that the loss of cystinosin is associated with disrupted autophagy dynamics, accumulation of distorted mitochondria, and increased oxidative stress, leading to abnormal proliferation and dysfunction of kidney cells. We discuss these molecular mechanisms driving nephropathic cystinosis. Further, we consider how unravelling molecular mechanisms supports the identification and development of new strategies for cystinosis by the use of small molecules, biologicals, and genetic rescue of the disease in vitro and in vivo.

Original languageEnglish
Pages (from-to)673-686
Number of pages14
JournalTrends in Molecular Medicine
Volume27
Issue number7
Early online date8 May 2021
DOIs
Publication statusPublished - 1 Jul 2021

Bibliographical note

Funding Information:
This work was financially supported by a grant from the Dutch Kidney Foundation (grant nr. 150KG19 ).

Publisher Copyright:
© 2021 Elsevier Ltd

Keywords

  • CTNS gene
  • cystinosis
  • lysosomal storage disorder
  • renal Fanconi syndrome
  • therapeutic strategies

Fingerprint

Dive into the research topics of 'Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis'. Together they form a unique fingerprint.

Cite this